Industry news

• RNC Pharma: Russians’ spending on medicines has reached a historic high

  04 December 2024 GxP news

  RNC Pharma reports that in October 2024, Russians’ total expenditure on pharmaceuticals reached an unprecedented 151.6 billion rubles, marking a new historical high. From January to October, the retail pharmaceutical market volume was 1.33 trillion rubles, a 16.6% increase from 2023. The main growth factor was the increase in drug prices, but the increase in household income also stimulated the transition to more expensive drugs.

• Most life sciences CEOs expect to grow their head counts over the next 3 years: KPMG survey

  04 December 2024 Kevin Dunleavy / Fierce Biotech

  On a routine basis in recent years, headlines about layoffs in the biopharma industry have surfaced as companies large and small have been cutting costs and restructuring. Over the last 10 days, for example, Fierce has written about dismissals at Bristol Myers Squibb, Novartis, Lexicon Pharmaceuticals, Johnson & Johnson, Gilead Sciences, Merck, Sonata Therapeutics, Medigene and Alector Therapeutics.

• Russia to conduct an experiment on monitoring dietary supplement manufacturers

  03 December 2024 GxP news

  Russia will launch a pilot project on March 1, 2025, to monitor labeled goods manufacturers, including dietary supplements. The key objective of the project is to create an effective system for verifying data on products and their manufacturers. A methodology will be developed for analyzing information and monitoring mechanisms, along with testing access restrictions to marking codes when violations occur. Particular attention is paid to creating a system for pre-trial appeal of operator decisions by manufacturers.

• Sustainable analytical approach devised for complex drug formulation

  03 December 2024 Catherine Eckford / European Pharmaceutical Review

  The innovative method uses spectroscopy and could enhance pharmaceutical quality assurance in resource-limited settings, the study suggests.

• Branches of Russian medical universities are planned to be opened in Kazakhstan

  02 December 2024 GxP news

  Russian Health Minister Mikhail Murashko engaged in discussions with Tamara Duseinova, the Deputy Prime Minister of Kazakhstan, and Akmaral Alnazarova, the country’s Health Minister. During the meeting, key issues of cooperation between the countries in the field of healthcare were discussed.

• AI and automation to drive “substantial progress” in pharmaceutical analytical testing

  02 December 2024 Catherine Eckford / European Pharmaceutical Review

  Analysis cites personalised medicine, outsourcing and digitalisation as some of the key factors set to advance the pharmaceutical analytical testing market to 2032.

• Study proposes system to produce endotoxin-free recombinant proteins

  29 November 2024 Catherine Eckford / European Pharmaceutical Review

  The system is distinguishable from other bacterial expression systems and can be applied in scenarios where minimal endotoxin contamination is an issue, according to the research.

• Most life sciences CEOs expect to grow their head counts over the next 3 years: KPMG survey

  29 November 2024 Kevin Dunleavy / FiercePharma

  On a routine basis in recent years, headlines about layoffs in the biopharma industry have surfaced as companies large and small have been cutting costs and restructuring. Over the last 10 days, for example, Fierce has written about dismissals at Bristol Myers Squibb, Novartis, Lexicon Pharmaceuticals, Johnson & Johnson, Gilead Sciences, Merck, Sonata Therapeutics, Medigene and Alector Therapeutics.

• AI and automation to drive “substantial progress” in pharmaceutical analytical testing

  28 November 2024 Catherine Eckford / European Pharmaceutical Review

  Analysis cites personalised medicine, outsourcing and digitalisation as some of the key factors set to advance the pharmaceutical analytical testing market to 2032.

• Iodine production to launch in Arkhangelsk region

  28 November 2024 GxP news

  In the Arkhangelsk region’s priority development area, known as the “Capital of the North,” plans are underway to establish a pharmaceutical production facility that will leverage the region’s local iodine reserves. Governor Alexander Tsybulsky shared this information during a meeting with Russian President Vladimir Putin, highlighting the project’s critical importance in light of the nation’s previous reliance on imported iodine supplies.